Injective Protocol (INJ) traded at $6.01 on September 10, 2026, marking a 4.30% decline over the prior 24 hours. The daily pullback came against a backdrop of notably stronger performance over longer timeframes, suggesting the session's dip may reflect short-term consolidation rather than a reversal of recent momentum.
Over the past seven days, INJ gained 23.50%, one of the more significant weekly advances in the broader crypto market. The 30-day picture was similarly constructive, with the token appreciating 34.16% over that stretch. Those figures place INJ among the stronger-performing digital assets across both measurement windows.
INJ's market capitalization stood at $0.61 billion as of the close of the reporting period. That valuation reflects the asset's positioning within the mid-tier segment of the cryptocurrency market, where price swings of this magnitude can have a pronounced effect on overall capitalization.
The daily decline trimmed some of the asset's recent gains without erasing them entirely. Whether the session's weakness represents a temporary pause or the beginning of a broader correction remains to be seen as market participants assess conditions heading into the days ahead.
